logo

Black Diamond Therapeutics Inc’s Shares Reel: 103.10% Quarterly Revenue Decline Amid 309.40M Market Cap

surveying

Black Diamond Therapeutics Inc had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $6.85 on 06/27/23, while the lowest price during the same period was $1.43 on 05/01/23.

52-week price history of BDTX Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Black Diamond Therapeutics Inc’s current trading price is -14.01% away from its 52-week high, while its distance from the 52-week low is 311.89%. The stock’s price range for this period has remained between $1.43 and $6.85. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.57 million for the day, which was noticeably lower compared to the shares’ average daily volume of 0.64 million over the last three months.

Financial Performance and Market Capitalization

Black Diamond Therapeutics Inc (BDTX) has experienced a quarterly rise of 103.10% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 309.40M and boasts a workforce of 54 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 4.02, with a change in price of +3.53. Similarly, Black Diamond Therapeutics Inc recorded 552,396 in trading volume during the last 100 days, posting a change of +149.58%.

BDTX Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for BDTX stands at 0.22. Similarly, the long-term debt-to-equity ratio is also 0.19.

BDTX Stock Stochastic Average

As of today, the raw stochastic average of Black Diamond Therapeutics Inc over the last 50 days is at 87.15%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 80.61%. Further, the company’s Stochastic %K and %D values for the last 20 days were 48.08% and 35.62%, respectively.

BDTX Stock Price Performance Analysis

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price gain of 109.61% this year. Over the last six months, there has been a weaker performance of 208.38%. The price of BDTX fallen by 20.20% during the last 30 days period. For the last 5-days stocks have improved 11.98%.

Most Popular